E-LIB Suche - Ergebnisse für: V. K. Lepakhin

1

Safe Use of Systemic Interferons for Multiple Sclerosis Tre..:

Snegireva, I. I. ; Darmostukova, M. A. ; Kazakov, A. S..
Pharmaceutical Chemistry Journal. 52 (2019) 10 - p. 863-864 , 2019

Link: https://doi.org/10.1007/..

2

Efficacies and Chemical Structures of Modern Drugs for Hepa..:

Kazakov, A. S. ; Lepakhin, V. K. ; Bukatina, T. M...
Pharmaceutical Chemistry Journal. 52 (2018) 6 - p. 497-500 , 2018

Link: https://doi.org/10.1007/..

3

DRUG-DRUG INTERACTIONS IIKE A REASON OF ADVERSE DRUG REACTI..:

Kazakov, A S ; Lepakhin, V K ; Astakhova, A V
I.P. Pavlov Russian Medical Biological Herald. 21 (2013) 3 - p. 70-76 , 2013

Link: https://doi.org/10.17816..

4

Implementation of international standards in clinical trial..:

Lepakhin, V.K. ; Cheltsov, V.V. ; Snitsarenko, V.Yu...
Pharmacological Research. 31 (1995) - p. 380 , 1995

Link: https://doi.org/10.1016/..

5

Seasonal changes in blood pressure and some parameters of c..:

Frolov, V. A. ; Matyev, �. S. ; Kazanskaya, T. A...
Bulletin of Experimental Biology and Medicine. 112 (1991) 4 - p. 1505-1507 , 1991

Link: https://doi.org/10.1007/..

6

Comparative investigation of the pharmacokinetics and bioac..:

Kozhanov, A. M. ; Kholodov, L. E. ; Belousov, Yu. B....
Pharmaceutical Chemistry Journal. 25 (1991) 12 - p. 841-846 , 1991

Link: https://doi.org/10.1007/..

7

Pharmacokinetical basis of the biological effects modificat..:

Lepakhin, V.K. ; Kholodov, L.E. ; Volkonsky, V.A....
European Journal of Pharmacology. 183 (1990) 5 - p. 1705-1706 , 1990

Link: https://doi.org/10.1016/..

8

THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICIN..:

R. N. Alyautdin ; B. K. Romanov ; V. K. Lepakhin..
https://www.risksafety.ru/jour/article/view/291. , 2022

Link: https://doaj.org/article..

9

Qualitative methods of benefit / risk assessment ; Качестве..:

A. P. Pereverzev ; A. N. Mironov ; N. D. Bunyatyan...
https://www.risksafety.ru/jour/article/view/302/499. , 2022

Link: https://www.risksafety.r..

10

LOCAL ANESTHETIC MYOTOXICITY:

B. K. Romanov ; A. P. Pereverzev ; A. N. Mironov..
https://www.risksafety.ru/jour/article/view/292. , 2022

Link: https://doaj.org/article..

11

On the safety of acetaminophen:

R. N. Alyautdin ; V. K. Lepakhin ; B. K. Romanov.
https://www.risksafety.ru/jour/article/view/298. , 2022

Link: https://doaj.org/article..

12

USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TER..:

A. P. Pereverzev ; A. N. Mironov ; N. D. Bunyatyan..
https://www.risksafety.ru/jour/article/view/311. , 2022

Link: https://doaj.org/article..

13

THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICIN..:

R. N. Alyautdin ; B. K. Romanov ; V. K. Lepakhin...
https://www.risksafety.ru/jour/article/view/291/488. , 2022

Link: https://www.risksafety.r..

14

On the safety of acetaminophen ; К вопросу ацетаминофена о ..:

R. N. Alyautdin ; V. K. Lepakhin ; B. K. Romanov...
https://www.risksafety.ru/jour/article/view/298/494. , 2022

Link: https://www.risksafety.r..

15

Qualitative methods of benefit / risk assessment:

A. P. Pereverzev ; A. N. Mironov ; N. D. Bunyatyan..
https://www.risksafety.ru/jour/article/view/302. , 2022

Link: https://doaj.org/article..